RXO's first quarter earnings signaled a tough several years for the company may have come to an end. The stock of its key competitor, C.H. Robinson, soared as investors took notice of the company's aggressive adoption of AI. This trend has been driven by regulatory changes in enforcement that began to accelerate late last year.
Instead of a surge in demand, Wilkerson said RXO is benefiting from a supply-driven recovery. Capacity continues to exit the market, a trend that began to accelerate due to regulatory changes.
The second factor that RXO officials kept coming back to is technology, and C.H. Robinson loomed large. The company's aggressive adoption of AI has driven steady increases in its performance since May 1, 2024.
C.H. Robinson executives have been about as 'on message' as might be found in any industry, referring to their unique disciplined approach to AI innovation that is transforming supply chains.
At RXO, they have talked about the adoption of AI, but it's never been as aggressive as heard from their competitor. That started to change with the first quarter earnings call.
Investors were reacting positively to RXO's forecast of EBITDA in the second quarter, which jumped significantly from $6 million in the first quarter.
The company is now forecasting $27 million to $37 million in EBITDA for the second quarter, based on higher pricing and productivity gains.
This assumption is based on the waning of the brokerage squeeze that occurs when spot rates are rising but contract rates are not. Investors will be watching as RXO recovers from tough years.
The shift towards supply-driven recovery and technology adoption will be key to RXO's long-term success, and investors are taking notice.
The shift towards supply-driven recovery and technology adoption will be key to RXO's long-term success.
